SYNOVEX PRIMER DIN 02551640
Health Canada record
| Active ingredient(s) | TRENBOLONE ACETATE 50 MG; ESTRADIOL BENZOATE 7 MG |
|---|---|
| Dosage form | Implant |
| Route | Subcutaneous |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 09-Apr-2025 |
| Current status date | 09-Apr-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRENBOLONE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02366916 | COMPONENT TE-100 IMPLANTS WITH TYLAN | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 100 MG; ESTRADIOL 10 MG; TYLOSIN TARTRATE 29 MG | Marketed |
| 02407760 | COMPONENT TE-200 IMPLANTS WITH TYLAN | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL 20 MG; TYLOSIN TARTRATE 29 MG | Marketed |
| 02245665 | COMPONENT TE-H IMPLANTS WITH TYLAN | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 140 MG; ESTRADIOL 14 MG; TYLOSIN TARTRATE 29 MG | Marketed |
| 02245745 | COMPONENT TE-S IMPLANTS WITH TYLAN | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 120 MG; ESTRADIOL 24 MG; TYLOSIN TARTRATE 29 MG | Marketed |
| 02429136 | REVALOR-100 | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 100 MG; ESTRADIOL 10 MG | Marketed |
| 02254026 | REVALOR-200 | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL 20 MG | Marketed |
| 02246207 | REVALOR-G | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 40 MG; ESTRADIOL 8 MG | Marketed |
| 02231280 | REVALOR-H | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 140 MG; ESTRADIOL 14 MG | Marketed |
| 02078589 | REVALOR-S | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 120 MG; ESTRADIOL 24 MG | Marketed |
| 02469219 | REVALOR-XH | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL 20 MG | Marketed |
| 02469316 | REVALOR-XR | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL 20 MG | Marketed |
| 02316994 | REVALOR-XS | INTERVET CANADA CORP | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL 40 MG | Marketed |
| 02247115 | SYNOVEX CHOICE | ZOETIS CANADA INC | Implant | TRENBOLONE ACETATE 100 MG; ESTRADIOL BENZOATE 14 MG | Marketed |
| 02485133 | SYNOVEX LA-F | ZOETIS CANADA INC | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL BENZOATE 28 MG | Marketed |
| 02485125 | SYNOVEX LA-G | ZOETIS CANADA INC | Implant | TRENBOLONE ACETATE 150 MG; ESTRADIOL BENZOATE 21 MG | Marketed |
| 02162830 | SYNOVEX PLUS | ZOETIS CANADA INC | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL BENZOATE 28 MG | Marketed |
| 02366908 | COMPONENT TE-200 IMPLANTS | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 200 MG; ESTRADIOL 20 MG | Dormant |
| 02427486 | COMPONENT TE-G IMPLANTS | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 40 MG; ESTRADIOL 8 MG | Dormant |
| 02244729 | COMPONENT TE-H IMPLANTS | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 140 MG; ESTRADIOL 14 MG | Dormant |
| 02237832 | COMPONENT TE-S IMPLANTS | ELANCO CANADA LIMITED | Implant | TRENBOLONE ACETATE 120 MG; ESTRADIOL 24 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35913 | 2025-08-28 | Supplement to a New Drug Submission (SNDS) | Additional indication |
| 34035 | 2024-09-18 | Supplement to a New Drug Submission (SNDS) | New strength |
International API supply for TRENBOLONE ACETATE
0 active FDA Drug Master Files.
Request a quote for SYNOVEX PRIMER